MedTrace Logo

Study of Chronic Degenerative Diseases

NCT02495961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2016-02-17

No results posted yet for this study

Summary

The prevalence of obesity and type 2 diabetes mellitus (DM) in children have been increasing in parallel at an alarming rate. In particular, the increasing prevalence of type 2 DM is attributable to genetic factors, clinical (waist circumference, adiposity and physical condition) and biochemical (insulin secretion and sensitivity, lipids and inflammation) risk, each of which represents an independent risk.

As has already studied and published in the investigators' group, the child population of Toluca has greater expression of cardiovascular risk factors than their counterparts in Bogota, Colombia. The metabolic characterization of the young population of Toluca and Bogota with new biomarkers such as homocysteine and leptin is an activity that aims to provide more metabolic data affecting young people.

Hypothesis:

After six months of follow-up there will be a greater relative risk in Mexican population to have identified another component of metabolic syndrome compared to the young population of Colombia.

Conditions

  • Metabolic Syndrome X

Sponsors & Collaborators

  • Universidad Autonoma del Estado de Mexico

    collaborator OTHER

  • Ciprés Grupo Médico CGM SC

    collaborator OTHER

  • Asociación Científica Latina A.C.

    lead OTHER

Principal Investigators

  • Hugo Mendieta Zerón, PhD. · Asociación Científica Latina A.C.

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-01-31
Completion
2016-02-29

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02495961 on ClinicalTrials.gov